Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists Δ9-THC, WIN 55,212-2 and anandamide in mice

Neuroscience Letters

Volumn 263, Issue 1, 1999, Pages 29-32

  Raffa, Robert B ^a   Stone Jr , Dennis J ^b,c   Hipp, Sean J ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b R W Johnson Pharmaceutical Res I   (United States)

^c DREXEL UNIVERSITY   (United States)

Author keywords

9 Tetrahydrocannabinol; Anandamide; Antinociception; Cannabinoid; Cholera toxin; Pertussis toxin; Supraspinal; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CHOLERA TOXIN; DRONABINOL; PERTUSSIS TOXIN;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CEREBRAL VENTRICLES; CHOLERA TOXIN; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED ICR; MORPHOLINES; NAPHTHALENES; PAIN; POLYUNSATURATED ALKAMIDES; SPINAL CORD;

EID: 0033583134     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00096-8     Document Type: Article

References (25)

1. Adams I.B., Compton D.R., Martin B.R. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther. 284:1998;1209-1217.
2. Barth F. Cannabinoid receptor agonists and antagaonists. Exp. Opin. Ther. Patents. 8:1998;301-313.
3. Burkey T.H., Quock R.M., Consroe P., Ehlert F., Hosohata Y., Roeske W.R., Yamamura H.I. Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Eur. J. Pharmacol. 336:1997;295-298.
4. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263:1992;1118-1129.
5. Devane W.A., Dysarc III F.A., Johnson M.R., Mevin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613.
6. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
7. Dewey W.L. Cannabinoid pharmacology. Pharmacol. Rev. 38:1986;151-178.
8. Di Marzo V., De Petrocellis L., Bisogno T., Maurelli S. Pharmacology and physiology of the endogenous cannabimimetic mediator anandamide. J. Drug Dev. Clin. Pract. 7:1995;199-219.
9. Felder C.C., Glass M. Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol. 38:1998;179-200.
10. Felder C.C., Nielsen A., Briley E.M., Palkovits M., Priller J., Axelrod J., Nguyen D.N., Richardson J.M., Riggin R.M., Koppel G.A., Paul S.M., Becker G.W. Isolation and measurement of the endogenous cannabinoid receptor agonist anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 393:1996;231-235.
11. 9-tetrahydrocannabinol. Brain Res. 697:1995;83-90.
12. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313-314.
13. Goode T.L., Raffa R.B. An examination of the relationship between μ-opioid antinociceptive efficacy and G-protein coupling using pertussis and cholera toxins. Life Sci. 60:1997;PL107-PL113.
14. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
15. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:1995;607-634.
16. Janssen P.A.J., Niemegeers C.J.E., Dony J.G.H. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneim-Forsch. 13:1963;502-507.
17. Mackie K., Devane W.A., Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44:1993;498-503.
18. 9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Life Sci. 62:1998;2431-2439.
19. Martin W.J., Lai N.K., Patrick S.L., Tsou K., Walker J.M. Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Res. 629:1993;300-304.
20. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
21. 9-tetrahydrocannabinol and antagonist activity of cannabinol on rat brain cannabinoid receptors. Life Sci. 63:1998;PL1-PL6.
22. Pertwee, R.G., Cannabinoid Receptors, Academic Press, London, 1995, 264 pp.
23. 9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 60:1998;559-566.
24. Sulcova E., Mechoulam R., Fride E. Biphasic effects of anandamide. Pharmacol. Biochem. Behav. 59:1998;347-352.
25. Vogel Z., Bayewitch M., Levy R., Matus-Leibovitch N., Hanus L., Ben-shabat S., Mechoulam R., Avidor-Reiss T., Barg J. Binding and functional studies with the peripheral and neuronal cannabinoid receptors. Regul. Pept. 54:1994;313-314.